Clinical trials: Solar Purpura
PURPURA
A Novel Oral Natural Extract for the Treatment of Senile Purpura
A randomized, double-blind, placebo controlled study to assess the safety and effectiveness of a novel oral natural extract to improve the appearance of the skin of patients with senile purpura.
- Trial name
- NCT01183910
- Testing
- Citrus Bioflavanoid Blend, Calcium Carbonate
- Where
- United States
- Volunteers
- 75 people, healthy volunteers welcome
- Sponsor
- Nexgen Dermatologics, Inc.
Senile Purpura
A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura
This is an open label 6 month pilot study for male and female participants over the age of 52 that desire treatment and prevention of senile purpura of the forearms.
- Trial name
- NCT01485367
- Testing
- adapalene gel 0.3%
- Where
- 2 sites in United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Multispecialty Aesthetic Clinical Research Organization
Senile Purpura, Bateman's Purpura
Broad Band Light for the Treatment and Prevention of Senile Purpura
There will be five subjects over the age of 65, each with at least one ecchymotic lesion on each arm measuring at least one cm, and five control subjects under the age of 35, both who will be randomized to undergo 4 Sciton Broad…
- Trial name
- NCT03690375
- Testing
- Broad Band Light (BBL)
- Where
- United States
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Siperstein Dermatology
Solar Purpura
Microneedling for Dermatoporosis
We hypothesize that a series of treatments with a microneedling protocol will lead to increased dermal thickness as measured by biopsy, ultrasound, and skin calipometry; an improvement in dermatology-related quality of life; and…
- Trial name
- NCT04912219
- Testing
- Microneedling
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- The Cooper Health System
Senile Purpura
Factors Associated With Dermatoporosis
Dermatoporosis is a chronic syndrome of skin insufficiency or fragility. It is characterized by cutaneous atrophy, senile purpura and stellate pseudoscars. Dermatoporosis prevalence is 37% in ≥65 years.
- Trial name
- FAWD (NCT05037604)
- Testing
- Questionnaire about associated factors, Self questionnaire diagnostic tool, Physical Examination
- Where
- Mexico
- Volunteers
- 315 people, healthy volunteers welcome
- Sponsor
- Universidad Autonoma de San Luis Potosí